Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Five9 Inc ha un obiettivo di prezzo di consenso pari a $45.12, stabilito in base alle ultime valutazioni degli analisti di 26. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, DA Davidson y DA Davidson il octubre 1, 2025, septiembre 12, 2025 y agosto 1, 2025. Con un obiettivo di prezzo medio di $28 tra le Wells Fargo, DA Davidson y DA Davidson, c'è un implicito 31.83% upside per Five9 Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/01/2025 | 31.83% | Wells Fargo | → $28 | Initiates | → Equal-Weight | |||
09/12/2025 | 31.83% | DA Davidson | $28 → $28 | Maintains | Neutral | |||
08/01/2025 | 31.83% | DA Davidson | $25 → $28 | Assumes | → Neutral | |||
08/01/2025 | 88.32% | Canaccord Genuity | $40 → $40 | Maintains | Buy | |||
08/01/2025 | 69.49% | Rosenblatt | $36 → $36 | Maintains | Buy | |||
07/14/2025 | 45.95% | Piper Sandler | $36 → $31 | Maintains | Overweight | |||
06/06/2025 | 64.78% | Keybanc | → $35 | Initiates | → Overweight | |||
05/13/2025 | 69.49% | Rosenblatt | $36 → $36 | Maintains | Buy | |||
05/05/2025 | 55.37% | Barclays | $60 → $33 | Maintains | Overweight | |||
05/02/2025 | 64.78% | UBS | $55 → $35 | Maintains | Buy | |||
05/02/2025 | 64.78% | RBC Capital | $30 → $35 | Maintains | Outperform | |||
05/02/2025 | 88.32% | Evercore ISI Group | $55 → $40 | Maintains | Outperform | |||
05/02/2025 | 69.49% | Rosenblatt | $36 → $36 | Maintains | Buy | |||
05/02/2025 | 88.32% | Needham | $52 → $40 | Maintains | Buy | |||
04/28/2025 | 31.83% | Jefferies | $45 → $28 | Maintains | Hold | |||
04/24/2025 | 69.49% | Rosenblatt | $58 → $36 | Maintains | Buy | |||
04/22/2025 | 8.29% | Wells Fargo | $45 → $23 | Maintains | Equal-Weight | |||
04/16/2025 | 31.83% | Morgan Stanley | $48 → $28 | Maintains | Equal-Weight | |||
04/15/2025 | 97.74% | Mizuho | $55 → $42 | Maintains | Outperform | |||
04/04/2025 | 144.82% | Needham | $52 → $52 | Reiterates | Buy → Buy | |||
04/04/2025 | 173.07% | Rosenblatt | $58 → $58 | Maintains | Buy | |||
03/20/2025 | 173.07% | Rosenblatt | $58 → $58 | Maintains | Buy | |||
03/19/2025 | 206.03% | RBC Capital | $65 → $65 | Reiterates | Outperform → Outperform | |||
03/17/2025 | 144.82% | Needham | $52 → $52 | Reiterates | Buy → Buy | |||
02/21/2025 | 168.36% | Cantor Fitzgerald | $46 → $57 | Maintains | Overweight | |||
02/21/2025 | 149.53% | Piper Sandler | $46 → $53 | Maintains | Overweight | |||
02/21/2025 | 144.82% | Needham | $52 → $52 | Reiterates | Buy → Buy | |||
02/21/2025 | 173.07% | Rosenblatt | $50 → $58 | Maintains | Buy | |||
02/21/2025 | 182.49% | Barclays | $55 → $60 | Maintains | Overweight | |||
01/21/2025 | 144.82% | Needham | $52 → $52 | Reiterates | Buy → Buy | |||
01/16/2025 | 116.57% | Cantor Fitzgerald | → $46 | Initiates | → Overweight | |||
12/18/2024 | 116.57% | Morgan Stanley | $40 → $46 | Maintains | Equal-Weight | |||
12/17/2024 | 206.03% | Truist Securities | $65 → $65 | Reiterates | Buy → Buy | |||
12/16/2024 | 144.82% | Needham | $48 → $52 | Maintains | Buy | |||
11/12/2024 | 88.32% | Wells Fargo | $55 → $40 | Downgrade | Overweight → Equal-Weight | |||
11/11/2024 | 102.45% | Baird | $40 → $43 | Maintains | Neutral | |||
11/08/2024 | 135.4% | Rosenblatt | $45 → $50 | Maintains | Buy | |||
11/08/2024 | 111.86% | DA Davidson | $40 → $45 | Maintains | Neutral | |||
11/08/2024 | 116.57% | Piper Sandler | $35 → $46 | Maintains | Overweight | |||
11/08/2024 | 125.99% | Needham | $48 → $48 | Reiterates | Buy → Buy | |||
10/23/2024 | 158.95% | Wells Fargo | $65 → $55 | Maintains | Overweight | |||
10/15/2024 | 74.2% | Morgan Stanley | $45 → $37 | Maintains | Equal-Weight | |||
08/27/2024 | 206.03% | Truist Securities | $65 → $65 | Maintains | Buy | |||
08/21/2024 | 121.28% | Piper Sandler | $47 → $47 | Reiterates | Overweight → Overweight | |||
08/21/2024 | 125.99% | Needham | $48 → $48 | Reiterates | Buy → Buy | |||
08/09/2024 | 229.57% | Rosenblatt | $80 → $70 | Maintains | Buy | |||
08/09/2024 | 125.99% | Needham | $90 → $48 | Maintains | Buy | |||
08/09/2024 | 135.4% | Northland Capital Markets | $95 → $50 | Maintains | Outperform | |||
08/09/2024 | 111.86% | BTIG | $100 → $45 | Maintains | Buy | |||
08/09/2024 | 206.03% | Wells Fargo | $80 → $65 | Maintains | Overweight | |||
08/09/2024 | 215.44% | Roth MKM | $90 → $67 | Maintains | Buy | |||
08/09/2024 | 121.28% | Piper Sandler | $58 → $47 | Maintains | Overweight | |||
08/09/2024 | 158.95% | Barclays | $75 → $55 | Maintains | Overweight | |||
08/09/2024 | 206.03% | Truist Securities | $100 → $65 | Maintains | Buy | |||
08/09/2024 | 88.32% | Baird | $90 → $40 | Downgrade | Outperform → Neutral | |||
08/05/2024 | 196.61% | B of A Securities | $63 → $63 | Upgrade | Underperform → Buy | |||
07/25/2024 | 253.11% | Barclays | $95 → $75 | Maintains | Overweight | |||
07/10/2024 | 173.07% | Piper Sandler | $86 → $58 | Maintains | Overweight | |||
06/14/2024 | 135.4% | Morgan Stanley | $70 → $50 | Maintains | Equal-Weight | |||
06/10/2024 | 276.65% | Wells Fargo | $85 → $80 | Maintains | Overweight | |||
06/06/2024 | 323.73% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
05/17/2024 | 323.73% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
05/03/2024 | 323.73% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
05/03/2024 | 281.36% | UBS | $90 → $81 | Maintains | Buy | |||
05/03/2024 | 300.19% | Wells Fargo | $90 → $85 | Maintains | Overweight | |||
05/03/2024 | 276.65% | Rosenblatt | $80 → $80 | Maintains | Buy | |||
04/26/2024 | 276.65% | Rosenblatt | $90 → $80 | Maintains | Buy | |||
04/22/2024 | 253.11% | Canaccord Genuity | $90 → $75 | Maintains | Buy | |||
04/17/2024 | 229.57% | Morgan Stanley | $80 → $70 | Maintains | Equal-Weight | |||
03/15/2024 | 276.65% | RBC Capital | → $80 | Initiates | → Outperform | |||
02/22/2024 | 323.73% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
02/22/2024 | 304.9% | Keybanc | $93 → $86 | Maintains | Overweight | |||
02/22/2024 | 323.73% | Wells Fargo | $100 → $90 | Maintains | Overweight | |||
02/22/2024 | 347.27% | Barclays | $105 → $95 | Maintains | Overweight | |||
02/15/2024 | 323.73% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
01/22/2024 | 337.85% | Keybanc | $86 → $93 | Maintains | Overweight | |||
01/12/2024 | 304.9% | Piper Sandler | $84 → $86 | Maintains | Overweight | |||
12/15/2023 | 323.73% | Deutsche Bank | $85 → $90 | Maintains | Buy | |||
12/05/2023 | 370.81% | Truist Securities | → $100 | Reiterates | Buy → Buy | |||
12/05/2023 | 370.81% | Wells Fargo | $90 → $100 | Maintains | Overweight | |||
12/05/2023 | 323.73% | Needham | → $90 | Reiterates | Buy → Buy | |||
11/20/2023 | 295.48% | Piper Sandler | $77 → $84 | Maintains | Overweight | |||
11/06/2023 | 323.73% | Rosenblatt | → $90 | Reiterates | Buy → Buy | |||
11/03/2023 | 262.52% | Piper Sandler | $94 → $77 | Maintains | Overweight | |||
11/03/2023 | 304.9% | Keybanc | $104 → $86 | Maintains | Overweight | |||
10/27/2023 | 323.73% | Rosenblatt | $105 → $90 | Maintains | Buy | |||
10/19/2023 | 276.65% | Morgan Stanley | $85 → $80 | Maintains | Equal-Weight | |||
09/21/2023 | 276.65% | Deutsche Bank | $75 → $80 | Upgrade | Hold → Buy | |||
09/19/2023 | 323.73% | Canaccord Genuity | → $90 | Reiterates | Buy → Buy | |||
09/15/2023 | 394.35% | Rosenblatt | → $105 | Reiterates | Buy → Buy | |||
08/08/2023 | 323.73% | Roth MKM | $80 → $90 | Maintains | Buy | |||
08/08/2023 | 347.27% | Wells Fargo | $90 → $95 | Maintains | Overweight | |||
08/08/2023 | 394.35% | Rosenblatt | → $105 | Reiterates | Buy → Buy | |||
08/08/2023 | 253.11% | Jefferies | $70 → $75 | Maintains | Hold | |||
08/08/2023 | 323.73% | Needham | → $90 | Reiterates | Buy → Buy | |||
07/26/2023 | 394.35% | Rosenblatt | $85 → $105 | Maintains | Buy | |||
07/21/2023 | 389.64% | Keybanc | $81 → $104 | Maintains | Overweight | |||
07/19/2023 | 300.19% | Morgan Stanley | $75 → $85 | Maintains | Equal-Weight | |||
06/08/2023 | 253.11% | DA Davidson | → $75 | Initiates | → Neutral | |||
05/31/2023 | 370.81% | Mizuho | → $100 | Initiates | → Buy |
El último precio objetivo de Five9 (NASDAQ:FIVN) fue comunicado por Wells Fargo el octubre 1, 2025. La firma de analistas fijó un precio objetivo para $28.00 que espera FIVN a rise dentro de 12 meses (un posible 31.83% upside). 41 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Five9 (NASDAQ:FIVN) fue proporcionada por Wells Fargo, y Five9 iniciado su equal-weight calificación.
La última revisión al alza de Five9 Inc se produjo en agosto 5, 2024, cuando B of A Securities elevó su precio objetivo a $63. B of A Securities anteriormente tenía an underperform para Five9 Inc.
La última revisión a la baja de Five9 Inc se produjo en noviembre 12, 2024, cuando Wells Fargo cambió su precio objetivo de $55 a $40 para Five9 Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Five9, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Five9 se registró el octubre 1, 2025, por lo que la próxima calificación estará disponible en torno al octubre 1, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Five9 (FIVN) fue un iniciado con un precio objetivo de $0.00 a $28.00. El precio actual al que cotiza Five9 (FIVN) es de $21.24, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.